Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,082 USD | -1.63% |
|
+2.84% | +23.21% |
07-12 | UBS Raises Price Target on Regeneron Pharmaceuticals to $1,250 From $1,124, Maintains Buy Rating | MT |
07-11 | Morgan Stanley Trims Price Target on Regeneron Pharmaceuticals to $1,182 From $1,183 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.21% | 117B | |
+20.63% | 127B | |
+25.12% | 27.67B | |
-20.17% | 20.33B | |
-17.08% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Morgan Stanley Trims Price Target on Regeneron Pharmaceuticals to $1,182 From $1,183